Rank 59 • MedTech & Devices
Exo
Develops handheld ultrasound devices and workflow software powered by proprietary silicon-chip technology.
Visit website- Signal Score
- 86.1
- Total raised
- $320M
- Stage
- Series C
- Founded
- 2015
- Headquarters
- Santa Clara, United States
- Region
- North America
Their signal
Exo is directly challenging Butterfly Network by integrating high-performance piezoelectric micromachined ultrasound transducer (pMUT) technology with seamless enterprise IT software for hospitals.
Signal Score 86.1editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in MedTech & Devices
Did we miss something?
Change, add or remove details on this company. Our desk reviews every request.
Figures are subjective research desk estimates compiled from public sources and refreshed monthly, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.